Evofem Biosciences, Inc. Common Stock
EVFM
EVFM was delisted on the 10th of August, 2022.
42 hedge funds and large institutions have $147M invested in Evofem Biosciences, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
17% more funds holding
Funds holding: 36 → 42 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less capital invested
Capital invested by funds: $194M → $147M (-$46.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$6.34M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$593K |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$522K |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$256K |
| 5 |
BlackRock
New York
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Woodford Investment Management
London,
United Kingdom
|
-$6.34M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.23M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$149K |
| 4 |
JP Morgan Chase
New York
|
-$103K |
| 5 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
-$100K |
EVFM Hedge Fund Activity: Q3 2019 in Review
42 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Evofem Biosciences, Inc. Common Stock (EVFM) for Q3 2019, worth a combined $147M — down 24% from $194M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new EVFM positions and 4 closed out — a net gain of 6 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was Jupiter Asset Management, opening a new position worth an estimated $6.34M. The largest seller was Woodford Investment Management, cutting an estimated $6.34M.
- 42 institutional investors held Evofem Biosciences, Inc. Common Stock (EVFM) as of Q3 2019, up from 36 in Q2 2019.
- Funds reported $147M of Evofem Biosciences, Inc. Common Stock stock for Q3 2019, down 24% quarter-over-quarter.
- 10 funds opened new Evofem Biosciences, Inc. Common Stock positions in Q3 2019 and 4 closed out, a net change of +6 holders.
- The largest Evofem Biosciences, Inc. Common Stock buyer in Q3 2019 was Jupiter Asset Management, an estimated $6.34M added.
- The largest Evofem Biosciences, Inc. Common Stock seller in Q3 2019 was Woodford Investment Management, an estimated $6.34M sold.
Based on aggregated 13F filings for Q3 2019.